![](https://wp-static.smartkarma.com/../assets/uploaded/2023/08/Smartkarma-Insight-Card-Square.png)
In today’s briefing:
- Silergy (6415.TT): Trial-Run with Vanguard, and Recent Stock Drops Represent an Entry Opportunity.
- Vanguard (5347.TT): The Utilization to Improve over 70% in 3Q24.
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
Silergy (6415.TT): Trial-Run with Vanguard, and Recent Stock Drops Represent an Entry Opportunity.
- We are surprised that Silergy Corp (6415 TT) is using Vanguard Intl Semiconductor (5347 TT) to trial-run products.
- The outlook for 2024 remains unchanged at over 20% YoY, and we still see a path to recovery ahead.
- We consider the recent drop from NTD$526 on June 14th to NTD$429 on July 5th as an opportunity to consider entering the stock.
Vanguard (5347.TT): The Utilization to Improve over 70% in 3Q24.
- We expect Vanguard’s utilization to improve from around 65% in 2Q24 to over 70% in 3Q24.
- Qualcomm Inc (QCOM US) and Monolithic Power Systems, Inc (MPWR US) are gradually increasing demand volume in 2Q24 and 3Q24.
- Currently, Vanguard is experiencing a correction from above NTD$142 on July 2nd.